Abstract
Sleep disturbances have been shown to be associated with adverse health outcomes including diabetes mellitus (DM), hypertension, and obesity. However, little is known about the relationship between sleep duration and diabetes complications. The present cross-sectional study aimed to examine the association between sleep duration and nephropathy in a population of type 2 DM patients. Diabetic patients aged ≥ 18 years who visited two outpatient clinics in Kermanshah from February 2014 to February 2015 entered the study. Demographic, anthropometric, and biochemical data, as well as information on sleep duration of participants within the past 4 weeks, were collected by an interviewer. Patients with estimated glomerular filtration rate (eGFR) ≤ 60 ml/24 h were excluded from the study. Proteinuria was defined as excretion of more than 150 mg protein in 24-h urine. Differences in urine protein and related variables were examined between four sleep duration groups (≤ 5, 6, 7, and ≥ 8 h). Linear and logistic regression analyses were employed to assess the association between sleep duration and diabetic nephropathy. Four hundred thirty-two patients (63.8% female) with a mean age of 54.68 ± 9.98 years were analyzed. There were statistically significant differences in age, body mass index, waist circumference, DM duration, HbA1C, total cholesterol, HDL cholesterol, triglyceride, uric acid, and urine protein between sleep duration groups. While adjusted linear regression showed no association between sleep duration and urine protein (p = 0.300), multivariable logistic regression revealed male gender, increased HbA1C, shorter sleep duration, increased DM duration, lower eGFR, higher DBP, decreased HDL-C, and higher uric acid levels to be statistically associated with proteinuria. Short sleep duration is adversely associated with proteinuria in type 2 DM patients with normal and near-normal kidney function.
Similar content being viewed by others
References
Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21. https://doi.org/10.1016/j.diabres.2011.10.029.
Haghdoost A, Rezazadeh-Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J. 2009;15(3):591–9.
Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh M, Safarian M, Esmaeili H, Parizadeh S, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singap Med J. 2008;49(7):571.
Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes care in Iran: where we stand and where we are headed. Annals of global health. 2015;81(6):839–50. https://doi.org/10.1016/j.aogh.2015.10.003.
Tanjani PT, Moradinazar M, Mottlagh ME, Najafi F. The prevalence of diabetes mellitus (DM) type II among Iranian elderly population and its association with other age-related diseases, 2012. Arch Gerontol Geriatr. 2015;60(3):373–9. https://doi.org/10.1016/j.archger.2014.11.012.
Amini M, Parvaresh E. Prevalence of macro- and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. Diabetes Res Clin Pract. 2009;83(1):18–25. https://doi.org/10.1016/j.diabres.2008.10.010.
Mousavi SSB, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi Journal of Kidney Diseases and Transplantation. 2014;25(3):697–702.
Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461. https://doi.org/10.1038/s41598-017-13379-z.
Rezaie L, Khazaie H, Yazdani F. Exploration of the experience of living with chronic insomnia: a qualitative study. Sleep Sci. 2016;9(3):179–85. https://doi.org/10.1016/j.slsci.2016.07.001.
Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004;56(5):497–502. https://doi.org/10.1016/j.jpsychores.2004.02.010.
Strine TW, Chapman DP. Associations of frequent sleep insufficiency with health-related quality of life and health behaviors. Sleep Med. 2005;6(1):23–7. https://doi.org/10.1016/j.sleep.2004.06.003.
Khazaie H, Chehri A, Sadeghi K, Heydarpour F, Soleimani A, Rezaei Z. Sleep hygiene pattern and behaviors and related factors among general population in west of Iran. Global journal of health science. 2016;8(8):53434. https://doi.org/10.5539/gjhs.v8n8p114.
Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414–20. https://doi.org/10.2337/dc09-1124.
Taheri S. The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity. Arch Dis Child. 2006;91(11):881–4. https://doi.org/10.1136/adc.2005.093013.
Patel SR, Malhotra A, White DP, Gottlieb DJ, Hu FB. Association between reduced sleep and weight gain in women. Am J Epidemiol. 2006;164(10):947–54. https://doi.org/10.1093/aje/kwj280.
Gottlieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, Punjabi NM. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep. 2006;29(8):1009–14.
Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–92. https://doi.org/10.1093/eurheartj/ehr007.
Ricardo AC, Goh V, Chen J, Cedillo-Couvert E, Kapella M, Prasad B, et al. Association of sleep duration, symptoms, and disorders with mortality in adults with chronic kidney disease. Kidney international reports. 2017;2(5):866–73. https://doi.org/10.1016/j.ekir.2017.05.002.
Pazouki A, Ravanbakhsh PZ, Mokhber S, Jesmi F, Pishgahroudsari M, Jolfaei AG. Comparing the excessive daytime sleepiness of obese and non-obese patients. Iranian Red Crescent Med J. 2016 (in press).
Barone MT, Menna-Barreto L. Diabetes and sleep: a complex cause-and-effect relationship. Diabetes Res Clin Pract. 2011;91(2):129–37. https://doi.org/10.1016/j.diabres.2010.07.011.
Carroll MF, Temte JL. Proteinuria in adults: a diagnostic approach. Am Fam Physician. 2000;62(6):1333–40.
Maracy M, Amini M, Kheirabadi G, Fakhari EM, Fakhari EN, Zonnari N. Comparison of night time sleep quality in type 2 diabetics, impaired glucose tolerance cases and non-diabetics. Iran J Endocrinol Metab. 2011;13(2):165–72.
Hedayati A, Pouresmail A, Gholampour Y, Dehghan A. The relation between sleep disorders and hemoglobin A1c levels in patients with type II diabetes mellitus. Medical Journal of Mashhad University of Medical Sciences. 2016;59(3):179–87.
Grandner MA, Schopfer EA, Sands-Lincoln M, Jackson N, Malhotra A. The relationship between sleep duration and body mass index depends on age. Obesity (Silver Spring, Md). 2015;23(12):2491–8. https://doi.org/10.1002/oby.21247.
Cooper AJ, Westgate K, Brage S, Prevost AT, Griffin SJ, Simmons RK. Sleep duration and cardiometabolic risk factors among individuals with type 2 diabetes. Sleep Med. 2015;16(1):119–25. https://doi.org/10.1016/j.sleep.2014.10.006.
Ford ES, Wheaton AG, Chapman DP, Li C, Perry GS, Croft JB. Associations between self-reported sleep duration and sleeping disorder with concentrations of fasting and 2-h glucose, insulin, and glycosylated hemoglobin among adults without diagnosed diabetes. Journal of diabetes. 2014;6(4):338–50. https://doi.org/10.1111/1753-0407.12101.
Shadyab AH, Kritz-Silverstein D, Laughlin GA, Wooten WJ, Barrett-Connor E, Araneta MRG. Ethnic-specific associations of sleep duration and daytime napping with prevalent type 2 diabetes in postmenopausal women. Sleep Med. 2015;16(2):243–9. https://doi.org/10.1016/j.sleep.2014.11.010.
Williams CJ, Hu FB, Patel SR, Mantzoros CS. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007;30(5):1233–40. https://doi.org/10.2337/dc06-2107.
Ohkuma T, Fujii H, Iwase M, Ogata-Kaizu S, Ide H, Kikuchi Y, et al. Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry. PLoS One. 2013;8(11):e78968. https://doi.org/10.1371/journal.pone.0078968.
Afsar B. The relationship between self-reported nocturnal sleep duration, daytime sleepiness and 24-h urinary albumin and protein excretion in patients with newly diagnosed type 2 diabetes. Primary care diabetes. 2013;7(1):39–44. https://doi.org/10.1016/j.pcd.2013.01.002.
Yamamoto R, Nagasawa Y, Iwatani H, Shinzawa M, Obi Y, Teranishi J, et al. Self-reported sleep duration and prediction of proteinuria: a retrospective cohort study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2012;59(3):343–55. https://doi.org/10.1053/j.ajkd.2011.08.032.
Choi H, Kim HC, Lee JY, Lee JM, Choi DP, Suh I. Sleep duration and chronic kidney disease: the Korean Genome and Epidemiology Study (KoGES)-Kangwha study. The Korean Journal of Internal Medicine. 2017;32(2):323–34. https://doi.org/10.3904/kjim.2015.400.
Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Sleep duration: how well do self-reports reflect objective measures? The CARDIA Sleep Study. Epidemiology (Cambridge, Mass). 2008;19(6):838–45. https://doi.org/10.1097/EDE.0b013e318187a7b0.
Acknowledgements
The authors wish to express their gratitude to all who participated in this study. The work was performed in partial fulfillment of the requirements for degree of Specialty in Internal Medicine of Tahereh Yavari M.D., in Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All patients signed a written informed consent after receiving full explanation on details and objectives of the study. The study was approved by the Ethics Committee of Kermanshah University of Medical Sciences. Data were collected anonymously and all principles of Helsinki’s Declaration were met throughout the study phases.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Naseri, R., Yavari, T., Eftekharzadeh, A. et al. Association between sleep duration and nephropathy in patients with type II diabetes mellitus. Int J Diabetes Dev Ctries 38, 375–380 (2018). https://doi.org/10.1007/s13410-017-0603-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-017-0603-0